- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- January 2025
- 140 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Report
- July 2024
- 151 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- July 2024
- 154 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- May 2024
- 35 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- September 2023
- 120 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- December 2023
- 219 Pages
Global
€4742EUR$4,995USD£4,000GBP
- Report
- December 2022
- 53 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- December 2021
- 52 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- November 2023
- 1300 Pages
Global
From €9489EUR$9,995USD£8,004GBP
- Report
- June 2023
- 1041 Pages
Europe
From €8539EUR$8,995USD£7,203GBP
- Report
- March 2023
- 479 Pages
Europe
From €8539EUR$8,995USD£7,203GBP
- Report
- March 2022
- 84 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- November 2024
- 79 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- November 2024
- 82 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- February 2023
- 8 Pages
Global
From €2990EUR$3,150USD£2,522GBP

Laser atherectomy devices are medical instruments used in the treatment of cardiovascular diseases, specifically for the removal of atherosclerosis from blood vessels. They form a subset of the wider cardiovascular devices market, which encompasses various products used in the diagnosis, treatment, and management of heart and blood vessel disorders. These specialized devices operate using laser technology to ablate or vaporize the plaque within arteries, thus restoring blood flow and alleviating symptoms associated with peripheral artery disease and coronary artery disease. The adoption of laser atherectomy devices is driven by their capacity to treat complex lesions that are difficult to manage with traditional angioplasty and stenting techniques. Moreover, advancements in laser technology, including the development of more sophisticated catheter systems and the integration of imaging technologies, have enhanced the safety and effectiveness of these devices.
Several companies are active in the laser atherectomy devices market. Some of the prominent players include Spectranetics (acquired by Philips), Cardiovascular Systems Inc. (CSI), and Boston Scientific Corporation. These companies compete in terms of technological innovation, quality and safety of the devices, and the range of applications they can address within cardiovascular care. They invest in research and development to improve their offerings and to meet the stringent regulatory standards set by health authorities. Show Less Read more